ResearchDx news

CPT PLA Reimbursement Code Approved in US for PromarkerD

July 3, 2025

PromarkerD test for diabetic kidney disease

ResearchDx and Proteomics International are pleased to announce the American Medical Association has approved a new dedicated CPT® Proprietary Laboratory Analyses (PLA) code for PromarkerD. This is a significant milestone and a key step toward future reimbursement coverage of the test by both Medicare and private health insurers in the United States.

ASX Release

Working on a diagnostic of your own?

From biomarker discovery to FDA clearance and CLIA testing, we can help.